Sintx Technologies, Inc.
General ticker "SINT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $5.1M (TTM average)
Sintx Technologies, Inc. follows the US Stock Market performance with the rate: 35.0%.
Estimated limits based on current volatility of 6.1%: low 3.43$, high 3.87$
Factors to consider:
- Total employees count: 23 as of 2024
- Top business risk factors: Insufficient funding, Net losses, Economic downturns and volatility, Labor/talent shortage/retention, IT system failures
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.41$, 7.86$]
- 2025-12-31 to 2026-12-31 estimated range: [1.42$, 4.91$]
Financial Metrics affecting the SINT estimates:
- Positive: with PPE of -0.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -312.20 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: 18.93 < Shareholder equity ratio, % of 41.37 <= 41.86
- Negative: 0.79 < Interest expense per share per price, % of 1.05
Short-term SINT quotes
Long-term SINT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.60MM | $2.63MM | $1.25MM |
| Operating Expenses | $11.94MM | $15.98MM | $15.29MM |
| Operating Income | $-11.34MM | $-13.36MM | $-14.05MM |
| Non-Operating Income | $-0.70MM | $5.10MM | $3.02MM |
| Interest Expense | $0.02MM | $0.00MM | $0.03MM |
| R&D Expense | $6.45MM | $8.71MM | $5.20MM |
| Income(Loss) | $-12.04MM | $-8.26MM | $-11.02MM |
| Profit(Loss)* | $-12.04MM | $-8.26MM | $-11.02MM |
| Stockholders Equity | $5.70MM | $8.77MM | $3.89MM |
| Inventory | $0.28MM | $0.89MM | $0.50MM |
| Assets | $15.77MM | $15.37MM | $9.41MM |
| Operating Cash Flow | $-10.26MM | $-14.12MM | $-8.64MM |
| Capital expenditure | $1.41MM | $0.53MM | $0.69MM |
| Investing Cash Flow | $-1.10MM | $-0.50MM | $-0.19MM |
| Financing Cash Flow | $3.34MM | $11.71MM | $9.09MM |
| Earnings Per Share** | $-39.92 | $-21.51 | $-14.80 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.